Literature DB >> 19899009

Long-term renal toxicity in children following fractionated total-body irradiation (TBI) before allogeneic stem cell transplantation (SCT).

Johanna Gerstein1, Andreas Meyer, Karl-Walter Sykora, Jörg Frühauf, Johann H Karstens, Michael Bremer.   

Abstract

PURPOSE: To retrospectively assess the incidence and time course of renal dysfunction in children (< or = 16 years) following total- body irradiation (TBI) before allogeneic stem cell transplantation (SCT). PATIENTS AND METHODS: Between 1986 and 2003, 92 children (median age, 11 years; range, 3-16 years) underwent TBI before allogeneic SCT. 43 of them had a minimum follow-up of 12 months (median, 51 months; range, 12-186 months) and were included into this analysis. Conditioning regimen included chemotherapy and fractionated TBI with 12 Gy (n = 26) or 11.1 Gy (n = 17). In one patient, renal dose was limited to 10 Gy by customized renal shielding due to known nephropathy prior to SCT. Renal dysfunction was defined as an increase of serum creatinine > 1.25 times the upper limit of age-dependent normal.
RESULTS: Twelve children (28%) experienced an episode of renal dysfunction after a median of 2 months (range, 1-10 months) following SCT. In all but one patient renal dysfunction was transient and resolved after a median of 8 months (range, 3-16 months). One single patient developed persistent renal dysfunction with onset at 10 months after SCT. None of these patients required dialysis. The actuarial 3-year freedom from persistent renal toxicity for children surviving > 12 months after SCT was 97.3%.
CONCLUSION: The incidence of persistent renal dysfunction after fractionated TBI with total doses < or = 12 Gy was very low in this analysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19899009     DOI: 10.1007/s00066-009-2022-8

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  27 in total

1.  Renal failure after bone-marrow transplantation.

Authors:  E P Cohen
Journal:  Lancet       Date:  2001-01-06       Impact factor: 79.321

2.  Total-body irradiation--role and indications: results from the German Registry for Stem Cell Transplantation (DRST).

Authors:  Frank Heinzelmann; Helmut Ottinger; Carl-Heinz Müller; Sandra Allgaier; Christoph Faul; Michael Bamberg; Claus Belka
Journal:  Strahlenther Onkol       Date:  2006-04       Impact factor: 3.621

3.  Renal toxicity after total body irradiation.

Authors:  Martin Borg; Timothy Hughes; Noemi Horvath; Michael Rice; Anthony C Thomas
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-11-15       Impact factor: 7.038

4.  [Therapy-associated late effects after irradiation of malignant diseases in childhood and adolescence. Feasibility analyses of a prospective multicenter register study].

Authors:  Tobias Bölling; Andreas Schuck; Christian Rübe; Stefan Hesselmann; Hildegard Pape; Karin Dieckmann; Barbara Pöllinger; Rolf-Dieter Kortmann; Irene Speiser-Held; Frank-Michael Meyer; Carmen Martini; Branka Asadpour; Beate Timmermann; Jörn D Beck; Thorsten Langer; Marios Paulides; Bernhard Schmidt; Normann Willich
Journal:  Strahlenther Onkol       Date:  2006-08       Impact factor: 3.621

5.  Prospective study of renal insufficiency after bone marrow transplantation.

Authors:  Joana E Kist-van Holthe; Charlotte A Goedvolk; Ronald Brand; Margreet H van Weel; Robbert G M Bredius; Jacques A van Oostayen; Jacques M J J Vossen; Bert J van der Heijden
Journal:  Pediatr Nephrol       Date:  2002-11-14       Impact factor: 3.714

6.  In vivo dosimetry with semiconducting diodes for dose verification in total-body irradiation. A 10-year experience.

Authors:  Ulla Ramm; Jörg Licher; Jussi Moog; Christian Scherf; Eugen Kara; Heinz-Dietrich Böttcher; Claus Rödel; Stephan Mose
Journal:  Strahlenther Onkol       Date:  2008-10-01       Impact factor: 3.621

7.  Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.

Authors:  R Miralbell; S Bieri; B Mermillod; C Helg; G Sancho; B Pastoors; A Keller; J M Kurtz; B Chapuis
Journal:  J Clin Oncol       Date:  1996-02       Impact factor: 44.544

Review 8.  Second tumors after oncologic treatment.

Authors:  Wolfgang Dörr; Thomas Herrmann
Journal:  Strahlenther Onkol       Date:  2008-02       Impact factor: 3.621

9.  Optimized conformal paraaortic lymph node irradiation is not associated with enhanced renal toxicity.

Authors:  Meinhard Nevinny-Stickel; Karin Poljanc; Britta C Forthuber; Dirk Heute; Andrea Posch; Judith Lechner; Beate Beer; Peter Lukas; Thomas Seppi
Journal:  Strahlenther Onkol       Date:  2007-07       Impact factor: 3.621

10.  Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission. Results and prognostic factors in 326 consecutive patients.

Authors:  Y Belkacémi; F Pène; E Touboul; B Rio; V Leblond; N C Gorin; A Laugier; C Gemici; M Housset; M Ozsahin
Journal:  Strahlenther Onkol       Date:  1998-02       Impact factor: 3.621

View more
  12 in total

1.  Comparison of total body irradiation before and after chemotherapy in pretreatment for hematopoietic stem cell transplantation.

Authors:  De-Zhi Li; Pei-Yan Kong; Jian-Guo Sun; Xin-Xin Wang; Guang-Hui Li; Yi-Bing Zhou; Zheng-Tang Chen
Journal:  Cancer Biother Radiopharm       Date:  2011-12-08       Impact factor: 3.099

Review 2.  Advanced-stage III/IV follicular lymphoma: treatment strategies for individual patients.

Authors:  Frank Heinzelmann; Hellmut Ottinger; Marianne Engelhard; Martin Soekler; Michael Bamberg; Martin Weinmann
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621

3.  Retrospective, monocentric analysis of late effects after Total Body Irradiation (TBI) in adults.

Authors:  Tobias Bölling; David Christoph Kreuziger; Iris Ernst; Hassan Elsayed; Normann Willich
Journal:  Strahlenther Onkol       Date:  2011-04-26       Impact factor: 3.621

4.  Total body irradiation (TBI) in pediatric patients. A single-center experience after 30 years of low-dose rate irradiation.

Authors:  Claudia Linsenmeier; Daniel Thoennessen; Laura Negretti; Jean-Pierre Bourquin; Tino Streller; Urs Martin Lütolf; Susanne Oertel
Journal:  Strahlenther Onkol       Date:  2010-11-08       Impact factor: 3.621

5.  Long-term results of total body irradiation in adults with acute lymphoblastic leukemia.

Authors:  Simone Marnitz; Alexander Zich; Peter Martus; Volker Budach; Ulrich Jahn; Oliver Neumann; Renate Arnold
Journal:  Strahlenther Onkol       Date:  2014-03-05       Impact factor: 3.621

6.  Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

Authors:  Esmee Cm Kooijmans; Arend Bökenkamp; Nic S Tjahjadi; Jesse M Tettero; Eline van Dulmen-den Broeder; Helena Jh van der Pal; Margreet A Veening
Journal:  Cochrane Database Syst Rev       Date:  2019-03-11

7.  Automatic treatment planning for VMAT-based total body irradiation using Eclipse scripting.

Authors:  Jose R Teruel; Sameer Taneja; Paulina E Galavis; K Sunshine Osterman; Allison McCarthy; Martha Malin; Naamit K Gerber; Christine Hitchen; David L Barbee
Journal:  J Appl Clin Med Phys       Date:  2021-02-10       Impact factor: 2.102

8.  Feasibility study of volumetric modulated arc therapy with Halcyon™ linac for total body irradiation.

Authors:  Takuya Uehara; Hajime Monzen; Mikoto Tamura; Masahiro Inada; Masakazu Otsuka; Hiroshi Doi; Kenji Matsumoto; Yasumasa Nishimura
Journal:  Radiat Oncol       Date:  2021-12-14       Impact factor: 3.481

9.  Dosimetric Evaluation Between the Conventional Volumetrically Modulated Arc Therapy (VMAT) Total Body Irradiation (TBI) and the Novel Simultaneous Integrated Total Marrow Approach (SIMBa) VMAT TBI.

Authors:  Dennis Stanley; Kristen McConnell; Zohaib Iqbal; Ashlyn Everett; Jonathan Dodson; Kimberly Keene; Andrew McDonald
Journal:  Cureus       Date:  2021-06-14

10.  Total Body Irradiation (TBI) using Helical Tomotherapy in children and young adults undergoing stem cell transplantation.

Authors:  Arne Gruen; Wolfram Ebell; Waldemar Wlodarczyk; Oliver Neumann; Joern Sven Kuehl; Carmen Stromberger; Volker Budach; Simone Marnitz
Journal:  Radiat Oncol       Date:  2013-04-15       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.